Overcoming cellular immunity to prolong adenoviral-mediated gene expression in sciatic nerve

Agnes Jani, Daniela Menichella, Huiyuan Jiang, Taibi Chbihi, Gyula Acsadi, John Kamholz, Michael E. Shy*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


In a previous report, we demonstrated that a first generation (E1-and E3-deleted) recombinant adenovirus can transduce expression of the E. coli lacZ gene into Schwann cells, both in vitro and in vivo, suggesting that this method might be useful for future therapy of peripheral neuropathy, including CMT1. Adenoviral-mediated gene transfer was limited, however, by demyelination and Wallerian degeneration at the site of virus injection, as well as by attenuation of viral gene expression over time. In our current work we have optimized adenoviral-mediated gene expression after intraneural injection into sciatic nerve. Using an improved injection protocol, peak expression of lacZ occurs between 10 and 14 days after injection of 2-week-old animals, decreases thereafter, and there is minimal associated tissue injury. In contrast, very few adenoviral-infected Schwann cells are found in nerves of adult animals 10 days after injection, probably due to immune clearance of viral-infected cells. Consistent with this notion, high levels of lacZ are found in sciatic nerve 30 days after injection of adult SCID mice, which have a genetic defect in both cellular and humoral immunity, of adult β2 microglobulin-deficient mice (β2 M -/-), which have a genetic defect in cellular immunity, or of adult mice treated with the immunosuppressing agent FK506. In addition, adenoviral-infected Schwann cells cocultured with axons in vitro, in the absence of a host immune response, ensheath axons and express lacZ for at least 8 weeks. These data thus demonstrate that expression of first generation recombinant adenovirus in sciatic nerve in adult mice, as in other tissues, is limited mainly by the host cellular immune response to the virus, which can be overcome by attenuation of host cell-mediated immunity. Adenoviral vectors might thus be used to modulate Schwann cell gene expression In patients with peripheral neuropathy after appropriate immunosuppression.

Original languageEnglish (US)
Pages (from-to)397-414
Number of pages18
JournalAnnals of the New York Academy of Sciences
StatePublished - 1999

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science


Dive into the research topics of 'Overcoming cellular immunity to prolong adenoviral-mediated gene expression in sciatic nerve'. Together they form a unique fingerprint.

Cite this